Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
Genes, Chromosomes and Cancer, 05/18/09
Kresse SH et al. – Study shows that limbic system-associated membrane protein (LSAMP) is a novel candidate tumor suppressor gene in osteosarcomas.
Methods- An analysis of the karyotype in osteosarcomas
- DNA copy number changes in 36 osteosarcoma tumors and 20 cell lines were examined using microarray-based comparative genomic hybridization
- Chromosomal deletion was validated using FISH
- Expression level and promoter methylation status were investigated using qRT-PCR and methylation-specific PCR, respectively
- Most frequent minimal recurrent regions of gain identified in the tumor samples were in 1q21.2-q21.3, 1q21.3-q22, and 8q22.1
- Minimal recurrent regions in 10q22.1-q22.2, 6q16.1, 13q14.2, and 13q21.1 were most frequently lost
- A small region in 3q13.31 (2.1 Mb) containing the gene LSAMP (a tumor suppressor gene) was frequently deleted
- LSAMP showed low expression in 6/15 tumors and 5/9 cell lines with deletion of 3q13.31
- Low expression also seen in 5/14 tumors and 3/11 cell lines with normal copy number or gain
- Partial or full methylation of the investigated CpG island was identified in 3/30 tumors and 7/20 cell lines
- Loss of 11p15.4-p15.3 and low expression of LSAMP were associated with poor survival
Related Articles
The role of interferons in the treatment of osteosarcoma
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 88%
Reconstruction Using a Frozen Bone Method for Osteosarcoma of the Talus. A Case Report and Review of the Literature
Anticancer Research, 11/11/09
Relevance Score: 88%
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
British Journal of Cancer, 11/06/09
Relevance Score: 88%
Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09
Relevance Score: 88%
Tumoral Calcinosis Mimicking Recurrent Osteosarcoma
Radiology Case Reports, 10/23/09
Relevance Score: 88%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09
Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by deltaNp73 in Neuroblastoma
Molecular Cancer Research, 12/04/09
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression
Virchows Archiv, 12/04/09
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients prognosis
Medical Oncology, 12/04/09
Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
Investigational New Drugs, 12/04/09
Interventional radiology procedures in the treatment of bone metastasis
Bulletin du Cancer, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


